Mostafa Sally Abdallah, Mohammad Mai H S, Negm Walaa A, Batiha Gaber El Saber, Alotaibi Saqer S, Albogami Sarah M, Waard Michel De, Tawfik Noha Z, Abdallah Hoda Y
Department of Medical Biochemistry and Molecular Biology, Faculty of Medicine, Mansoura University, Mansoura, Egypt.
Department of Clinical Pathology, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Front Med (Lausanne). 2022 Oct 20;9:988962. doi: 10.3389/fmed.2022.988962. eCollection 2022.
Numerous microRNAs (miRNAs) have been found to have an aberrant expression in the peripheral blood or psoriasis patients' lesions. Psoriasis was shown to have the abnormal expression of microRNA-203 (miR-203). It is a skin-specific signal that governs cellular proliferation in a protein kinase C-dependent manner and is mostly generated by keratinocytes. This work evaluated the expression levels of the circulating miR-203 target genes SOCS3, SOCS6, TP63, TNF-, IL8, and IL24 in psoriasis patients. Using a relative quantitation PCR technique, we determined the expression levels of miR-203 and its target genes (SOCS3, SOCS6, TP63, TNF-, IL8, and IL24) in the plasma of 120 psoriatic patients and matched healthy controls. The disease characteristics of the patients were then correlated with the expression results. We also conducted numerous enrichment analyses for the diseases, functions, and pathways connected to the under-researched biomarkers. Compared to healthy controls, psoriatic patients had significantly increased levels of miR-203 expression; 7.1 (4.4-9.9). In contrast, psoriatic patients had significantly lower expression of all the examined genes compared to healthy controls. Regarding all the study biomarkers, the receiver operating characteristic (ROC) curve analysis demonstrated significant sensitivity and specificity for differentiating between psoriatic patients and healthy controls. According to the results of the disease matching score generated by miR-203 and its target genes, psoriasis was ranked first with a score of 4.45. The third-place finisher with a value of 3.98, it also demonstrated that miR-203 and its target genes are connected to various skin disorders. Our results show that miR-203 contributes to psoriasis pathogenesis not only locally in skin lesions but also in circulation, indicating that it may contribute to the systemic symptoms of the illness. MiR-203 overexpression in psoriasis suggests that miR-203 may be involved in an anti-inflammatory response because it targets both SOCS gene family members and pro-inflammatory cytokines.
众多微小RNA(miRNA)已被发现在外周血或银屑病患者的皮损中表达异常。银屑病被证实存在微小RNA - 203(miR - 203)的异常表达。它是一种皮肤特异性信号,以蛋白激酶C依赖的方式调控细胞增殖,主要由角质形成细胞产生。本研究评估了银屑病患者循环中miR - 203靶基因SOCS3、SOCS6、TP63、TNF - 、IL8和IL24的表达水平。采用相对定量PCR技术,我们测定了120例银屑病患者血浆及匹配的健康对照中miR - 203及其靶基因(SOCS3、SOCS6、TP63、TNF - 、IL8和IL24)的表达水平。然后将患者的疾病特征与表达结果进行关联分析。我们还对与研究较少的生物标志物相关的疾病、功能和通路进行了大量富集分析。与健康对照相比,银屑病患者miR - 203表达水平显著升高;为7.1(4.4 - 9.9)。相反,与健康对照相比,银屑病患者所有检测基因的表达均显著降低。对于所有研究的生物标志物,受试者工作特征(ROC)曲线分析显示在区分银屑病患者和健康对照方面具有显著的敏感性和特异性。根据miR - 203及其靶基因产生的疾病匹配评分结果,银屑病以4.45分排名第一。以3.98分位居第三,这也表明miR - 203及其靶基因与多种皮肤疾病有关。我们的结果表明,miR - 203不仅在皮肤病变局部,而且在循环中都对银屑病发病机制有作用,表明它可能与该疾病的全身症状有关。银屑病中miR - 203的过表达表明,miR - 203可能参与抗炎反应,因为它靶向SOCS基因家族成员和促炎细胞因子。